SE0401631D0 - New Composition - Google Patents
New CompositionInfo
- Publication number
- SE0401631D0 SE0401631D0 SE0401631A SE0401631A SE0401631D0 SE 0401631 D0 SE0401631 D0 SE 0401631D0 SE 0401631 A SE0401631 A SE 0401631A SE 0401631 A SE0401631 A SE 0401631A SE 0401631 D0 SE0401631 D0 SE 0401631D0
- Authority
- SE
- Sweden
- Prior art keywords
- new composition
- treatment
- composition
- prophylaxis
- disclosed
- Prior art date
Links
- 238000011282 treatment Methods 0.000 abstract 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 abstract 2
- 238000011321 prophylaxis Methods 0.000 abstract 2
- 102000010445 Lactoferrin Human genes 0.000 abstract 1
- 108010063045 Lactoferrin Proteins 0.000 abstract 1
- 108010033276 Peptide Fragments Proteins 0.000 abstract 1
- 102000007079 Peptide Fragments Human genes 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 abstract 1
- 235000014655 lactic acid Nutrition 0.000 abstract 1
- 239000004310 lactic acid Substances 0.000 abstract 1
- 229940078795 lactoferrin Drugs 0.000 abstract 1
- 235000021242 lactoferrin Nutrition 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gynecology & Obstetrics (AREA)
- Urology & Nephrology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (15)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0401631A SE528337C2 (sv) | 2004-06-23 | 2004-06-23 | Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet |
| BRPI0512503-0A BRPI0512503A (pt) | 2004-06-23 | 2005-06-23 | composição que compreende ácido lático e lactoferrina |
| NZ552764A NZ552764A (en) | 2004-06-23 | 2005-06-23 | Composition comprising lactic acid and lactoferrin |
| PCT/SE2005/000989 WO2006001766A1 (en) | 2004-06-23 | 2005-06-23 | Composition comprising lactic acid and lactoferrin |
| KR1020077001696A KR20070048170A (ko) | 2004-06-23 | 2005-06-23 | 젖산 및 락토페린을 포함하는 조성물 |
| AT05755054T ATE464045T1 (de) | 2004-06-23 | 2005-06-23 | Zusammensetzung aus milchsäure und lactoferrin |
| US11/628,664 US20080161234A1 (en) | 2004-06-23 | 2005-06-23 | Composition Comprising Lactic Acid and Lactoferrin |
| JP2007518008A JP2008503576A (ja) | 2004-06-23 | 2005-06-23 | 乳酸およびラクトフェリンを含む組成物 |
| DE602005020639T DE602005020639D1 (de) | 2004-06-23 | 2005-06-23 | Zusammensetzung aus milchsäure und lactoferrin |
| EP05755054A EP1784176B1 (en) | 2004-06-23 | 2005-06-23 | Composition comprising lactic acid and lactoferrin |
| RU2007102273/15A RU2398575C2 (ru) | 2004-06-23 | 2005-06-23 | Композиция, содержащая молочную кислоту и лактоферрин |
| CA002571183A CA2571183A1 (en) | 2004-06-23 | 2005-06-23 | Composition comprising lactic acid and lactoferrin |
| ZA200703166A ZA200703166B (en) | 2004-06-23 | 2005-06-23 | Composition comprising lactic acid and lactoferrin |
| CNA2005800206978A CN1972683A (zh) | 2004-06-23 | 2005-06-23 | 包含乳酸和乳铁传递蛋白的组合物 |
| AU2005257722A AU2005257722B2 (en) | 2004-06-23 | 2005-06-23 | Composition comprising lactic acid and lactoferrin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0401631A SE528337C2 (sv) | 2004-06-23 | 2004-06-23 | Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| SE0401631D0 true SE0401631D0 (sv) | 2004-06-23 |
| SE0401631L SE0401631L (sv) | 2005-12-24 |
| SE528337C2 SE528337C2 (sv) | 2006-10-24 |
Family
ID=32768753
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE0401631A SE528337C2 (sv) | 2004-06-23 | 2004-06-23 | Sammansättning innefattande mjölksyra och laktoferrin, eller ett peptidfragment därav, och användning av denna sammansättning för behandling av tillstånd i urogenitalsystemet |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20080161234A1 (sv) |
| EP (1) | EP1784176B1 (sv) |
| JP (1) | JP2008503576A (sv) |
| KR (1) | KR20070048170A (sv) |
| CN (1) | CN1972683A (sv) |
| AT (1) | ATE464045T1 (sv) |
| AU (1) | AU2005257722B2 (sv) |
| BR (1) | BRPI0512503A (sv) |
| CA (1) | CA2571183A1 (sv) |
| DE (1) | DE602005020639D1 (sv) |
| NZ (1) | NZ552764A (sv) |
| RU (1) | RU2398575C2 (sv) |
| SE (1) | SE528337C2 (sv) |
| WO (1) | WO2006001766A1 (sv) |
| ZA (1) | ZA200703166B (sv) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100801891B1 (ko) * | 2006-11-02 | 2008-02-12 | 한상진 | 천연물질을 이용한 생식기 염증 예방 또는 치료용 약제학적 조성물 |
| CN103830216B (zh) | 2007-03-30 | 2016-08-17 | 莱克瑞股份公司 | 乳酸低聚物在制备用于治疗妇科病的药物中的应用 |
| EP2130531A1 (en) * | 2008-06-04 | 2009-12-09 | Rolf Kullgren AB | Vaginal suppository comprising lactic acid |
| GEP20146013B (en) * | 2009-01-23 | 2014-01-27 | Aziende Chimiche Riunite Angelini Francesco A C R A F S P A It | Controlled release pharmaceutical or food formulation and method of preparation thereof |
| KR101133723B1 (ko) * | 2009-10-19 | 2012-04-09 | 최원석 | 소금 및 당을 유효성분으로 함유하는 질염 예방 및 치료용 조성물 및 이의 용도 |
| WO2012031186A1 (en) | 2010-09-03 | 2012-03-08 | Wisconsin Pharmacal Company, Llc. | Prebiotic suppositories |
| CA2875784C (en) * | 2012-07-16 | 2020-03-10 | Laccure Ab | Pharmaceutical compositions containing oligomeric lactic acid |
| ITMI20122152A1 (it) * | 2012-12-17 | 2014-06-18 | Progine Farmaceutici S R L | Composizione per uso topico. |
| EP2992894A1 (en) * | 2014-09-05 | 2016-03-09 | Progine Farmaceutici Srl | Vaginal formulations for preventing and treating vaginal and cervico-vaginal infections |
| RU2637649C2 (ru) * | 2014-10-30 | 2017-12-05 | Федеральное государственное автономное образовательное учреждение высшего образования "Национальный исследовательский Томский государственный университет" (ТГУ, НИ ТГУ) | Способ и реагент-индикатор для рН-метрии вагинальной жидкости |
| MX2017016991A (es) * | 2017-12-20 | 2019-06-21 | Centro De Retina Medica Y Quirurgica S C | Formulación para la administración oral de extracto de arándano azul como auxiliar en la conservación de la salud de la película lagrimal en seres humanos. |
| KR102683248B1 (ko) | 2021-11-10 | 2024-07-10 | 장효영 | 질염 예방 및 치료를 위한 주입형 질 유산균 조성물 |
| EP4260869A1 (en) * | 2022-04-11 | 2023-10-18 | Reckitt Benckiser Health Limited | Composition comprising a combination of lactoferrin and a sulphated polysaccharide |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE8603338D0 (sv) * | 1986-08-07 | 1986-08-07 | Bjorn Andersch | Medel for behandling av tillstand i slidan |
| EP0629347B1 (en) * | 1992-01-23 | 1997-07-02 | Morinaga Milk Industry Co., Ltd. | Antibacterial agent and treatment of article therewith |
| JP2001504447A (ja) * | 1996-08-12 | 2001-04-03 | エイプラス サイエンス インベスト アーベー | ラクトフェリンおよび／またはラクトフェリシンでの、感染、炎症および／または腫瘍の処置および予防 |
| CN1304313A (zh) * | 1998-06-05 | 2001-07-18 | 若素制药株式会社 | 含乳酸菌的组合物、药物和食物 |
| US6240320B1 (en) * | 1998-06-05 | 2001-05-29 | Intermedics Inc. | Cardiac lead with zone insulated electrodes |
| JP3439686B2 (ja) * | 1999-03-30 | 2003-08-25 | 雪印乳業株式会社 | 鉄強化飲料 |
| IT1317937B1 (it) * | 2000-11-17 | 2003-07-15 | Sigma Tau Healthscience Spa | Composizione per stimolare le difese immunitarie ed il metabolismo delferro comprendente una alcanoil l-carnitina e lattoferrina. |
-
2004
- 2004-06-23 SE SE0401631A patent/SE528337C2/sv not_active IP Right Cessation
-
2005
- 2005-06-23 KR KR1020077001696A patent/KR20070048170A/ko not_active Application Discontinuation
- 2005-06-23 JP JP2007518008A patent/JP2008503576A/ja not_active Abandoned
- 2005-06-23 CA CA002571183A patent/CA2571183A1/en not_active Abandoned
- 2005-06-23 AU AU2005257722A patent/AU2005257722B2/en not_active Ceased
- 2005-06-23 CN CNA2005800206978A patent/CN1972683A/zh active Pending
- 2005-06-23 BR BRPI0512503-0A patent/BRPI0512503A/pt not_active IP Right Cessation
- 2005-06-23 EP EP05755054A patent/EP1784176B1/en active Active
- 2005-06-23 US US11/628,664 patent/US20080161234A1/en not_active Abandoned
- 2005-06-23 ZA ZA200703166A patent/ZA200703166B/xx unknown
- 2005-06-23 RU RU2007102273/15A patent/RU2398575C2/ru not_active IP Right Cessation
- 2005-06-23 NZ NZ552764A patent/NZ552764A/en not_active IP Right Cessation
- 2005-06-23 DE DE602005020639T patent/DE602005020639D1/de active Active
- 2005-06-23 AT AT05755054T patent/ATE464045T1/de not_active IP Right Cessation
- 2005-06-23 WO PCT/SE2005/000989 patent/WO2006001766A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| NZ552764A (en) | 2010-03-26 |
| RU2007102273A (ru) | 2008-07-27 |
| EP1784176B1 (en) | 2010-04-14 |
| RU2398575C2 (ru) | 2010-09-10 |
| ZA200703166B (en) | 2008-08-27 |
| DE602005020639D1 (de) | 2010-05-27 |
| EP1784176A1 (en) | 2007-05-16 |
| AU2005257722A1 (en) | 2006-01-05 |
| WO2006001766A1 (en) | 2006-01-05 |
| CA2571183A1 (en) | 2006-01-05 |
| CN1972683A (zh) | 2007-05-30 |
| BRPI0512503A (pt) | 2008-03-11 |
| ATE464045T1 (de) | 2010-04-15 |
| KR20070048170A (ko) | 2007-05-08 |
| SE0401631L (sv) | 2005-12-24 |
| US20080161234A1 (en) | 2008-07-03 |
| AU2005257722B2 (en) | 2009-03-12 |
| JP2008503576A (ja) | 2008-02-07 |
| SE528337C2 (sv) | 2006-10-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE464045T1 (de) | Zusammensetzung aus milchsäure und lactoferrin | |
| PH12017502286A1 (en) | Monoclonal antibodies against tissue factor pathway by inhibitor (tfpi) | |
| ATE551063T1 (de) | Verwendung von bifidobacterium longum zur prophylaxe und behandlung von entzündungen | |
| MX341883B (es) | Composicion farmaceutica para el tratamiento y prevencion de canceres. | |
| UA90048C2 (ru) | Кондиционированная композиция и способ ее получения | |
| EA201070121A1 (ru) | Лекарственная форма, содержащая слитый белок glp-1-fc | |
| NZ594814A (en) | Peptide that is derived from a milk protein and has an antioxidative effect and also acts as a blood adiponectin level increase promotion and/or decrease inhibition agent | |
| NZ617196A (en) | Activin-actrii antagonists and uses for increasing red blood cell levels | |
| MX2010002716A (es) | Uso de slit, nefrina, efrina o semaforina para el tratamiento de enfermedades de cartilago. | |
| SG170828A1 (en) | Deazapurines useful as inhibitors of janus kinases | |
| MX2010008206A (es) | Metodos y composiciones que utilizan polipeptidos de fusion de klotho-fgf. | |
| MY153198A (en) | Inhibitors of protein aggregation | |
| IL182218A0 (en) | Preparation and use of biphenyl-4-yl-carbonylamino and derivatives for the treatment of obesity | |
| WO2007095288A3 (en) | Methionine-containing protein or peptide compositions and methods of making and using | |
| BRPI0511367A (pt) | uso de uma composição,composição, uso de vip e/ou de um fragmento ativo do mesmo | |
| WO2007025977A3 (en) | Anti-tnf alpha producing lactic acid bacteria for the treatment of chronic enterocolitis | |
| MY138708A (en) | Biaryloxymethylarenecarboxylic acids | |
| WO2005023185A3 (en) | Pharmaceutical compositions and method of using levodopa and carbidopa | |
| WO2008079270A3 (en) | Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis | |
| GB2453491A (en) | Immunogenic proteins of burkholderia pseudomallei and uses thereof | |
| HK1106253A1 (en) | Desoxo-nonadepsipeptides | |
| ATE455789T1 (de) | Substituierte nonadepsipeptide | |
| WO2007134118A3 (en) | Protein based composition and methods of using same | |
| ZA200809686B (en) | Lysobactin amindes | |
| UA107177C2 (uk) | Імуногенна композиція цвс2 та спосіб приготування такої композиції |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NUG | Patent has lapsed |